Normal Liver Stiffness by MR Elastography

Determination of Normal Liver Stiffness by MR Elastography in Children

Healthy children will be recruited to under Magnetic Resonance Imaging (MRI)along with MR elastography to determine normal liver stiffness values.

Study Overview

Status

Completed

Conditions

Detailed Description

MR elastography (MRE) is playing a growing role in the non-invasive diagnosis and monitoring of liver disease in the pediatric population. There is, however, little data specific to the use of this technique in children with existing data and techniques largely extrapolated from adult studies. Existing studies suggest that liver stiffness values may be different between children and adults [Etchell, Xanthakos]. As such there is an unmet need for uniquely pediatric data in both healthy and diseased cohorts. To address the need for such data, the investigators plan a multi-site, prospective study of healthy pediatric (<18 years of age) volunteers to determine normal liver stiffness measured by MR elastography across the range of MRI equipment.

Study Type

Interventional

Enrollment (Actual)

101

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Cincinnati Children's Hospital Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 7-17 years
  • No documented history of liver diseases
  • English speaking

Exclusion Criteria:

  • NPO less than 4 hours
  • Body mass index <10th or > 85th percentile for age
  • Documented history of liver disease
  • Pregnancy
  • Inability to lie still for duration of the MRI
  • Inability to breath hold for the duration of the 15-20 second MR elastography sequence
  • Standard contraindication to MRI (implanted hardware, etc.)
  • Requirement of sedation or general anesthesia for MRI
  • Abnormality of any measured liver function test
  • Liver fat fraction >5% by MRI PDFF

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Normals
Will receive an MRI and a blood draw
Will receive a one time research MRI (MR elastography)
Will receive a one time blood draw to confirm healthy liver status

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Liver Stiffness
Time Frame: During investigation

Liver stiffness is a measure of a mechanical property of tissue (stiffness). This can be measured non-invasively by MR elastography, a technique that involves applying an external vibration to the abdomen and measuring the progression of shear waves through the underlying liver using MRI.

Purpose of the study was to determine normal (healthy) liver stiffness as measured by MRE

During investigation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cross-platform Variability
Time Frame: During Investigation
To assess for cross-platform (different MRI vendors) variability in normal MRI liver stiffness values
During Investigation
Cross-field Strength
Time Frame: During investigation
To assess cross-field strength (1.5T vs. 3T) variability in normal MRI liver stiffness values
During investigation
Sex-related Differences
Time Frame: During investigation
To assess for sex-related (male vs. female) differences in normal MRI liver stiffness values
During investigation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Trout, MD, Children's Hospital Medical Center, Cincinnati

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 19, 2018

Primary Completion (Actual)

June 25, 2020

Study Completion (Actual)

July 24, 2020

Study Registration Dates

First Submitted

July 28, 2017

First Submitted That Met QC Criteria

July 28, 2017

First Posted (Actual)

August 1, 2017

Study Record Updates

Last Update Posted (Actual)

September 16, 2020

Last Update Submitted That Met QC Criteria

August 27, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CIN001-Liver stiffness

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Liver Diseases

Clinical Trials on MRI

Subscribe